Therefore, deregulation in the expression of ISG15 may be expected to have pro-tumor functions, and thus an increased ISG15 level may promote carcinogenesis, giving the possibility of its use as a high-confidence diagnostic, therapeutic, and immunostimulant tumor biomarker [41,42]. The gene discussed is ISG15; the disease is neoplasm.